Neuropathix, Inc.

NPTX · OTC
Analyze with AI
3/31/2022
12/31/2021
9/30/2021
6/30/2021
Operating Activities
Net Income-$1,596-$757-$721-$751
Dep. & Amort.$32$7$5$5
Deferred Tax$0$19$74-$21
Stock-Based Comp.$277$309$291$298
Change in WC-$22$357$192$122
Other Non-Cash$1,194$34$16$78
Operating Cash Flow-$114-$31-$143-$270
Investing Activities
PP&E Inv.$0$39$0-$7
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$31$0$0
Investing Cash Flow$0$8$0-$7
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$54$20$0$56
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$200$33$97$4
Financing Cash Flow$200$33$97$4
Forex Effect$0$0$0$0
Net Chg. in Cash$87$10-$45-$272
Supplemental Information
Beg. Cash$16$6$51$323
End Cash$102$16$6$51
Free Cash Flow-$114$8-$143-$276
Neuropathix, Inc. (NPTX) Financial Statements & Key Stats | AlphaPilot